skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Update on new approaches in the management of hepatocellular carcinoma

Review

(2498) Views  (1058) Full article downloads

Authors: Giuseppe Cabibbo, Michela Antonucci, Chiara Genco

Published Date November 2010 Volume 2010:2 Pages 163 - 172
DOI: http://dx.doi.org/10.2147/HMER.S7132

Giuseppe Cabibbo1,2, Michela Antonucci3, Chiara Genco1
1Sezione di Gastroenterologia, Di.Bi.Mi.S., University of Palermo, Italy; 2Dipartimento di Biopatologia e Metodologie Biomediche, University of Palermo, Italy; 3Department of Oncology, Division of General and Oncological Surgery, University of Palermo, Italy

Abstract: Hepatocellular carcinoma (HCC) is a major health problem. It is currently the third cause of cancer-related death, it is highly prevalent in the Asia–Pacific region and Africa, and is increasing in Western countries. The natural history of HCC is very heterogeneous and prediction of survival in individual patients is not satisfactory because of the wide spectrum of the disease. During the past decade, major advances have been achieved in prevention, through better surveillance of patients at risk, and in therapy through better surgical and ablative therapies and multimodal treatment approaches. Moreover, the increasing knowledge of molecular hepatocarcinogenesis provides the opportunity for targeted therapies. In this setting, the impact of sorafenib on advanced-stage HCC is a landmark finding in the treatment of liver cancer. The role of sorafenib administration as adjuvant therapy after curative treatment is being evaluated in clinical studies. Future research should lead to a molecular classification of the disease and a more personalized treatment approach.

Keywords: hepatocellular carcinoma, sorafenib






Readers of this article also read:

Mechanism of the inhibitory effect of ghrelin in sepsis
Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes
Liver stiffness: a novel parameter for the diagnosis of liver disease
Optimal management of hepatorenal syndrome in patients with cirrhosis
Factors determining effectiveness of interferons in managing hepatitis C: new targets and new approaches
Potential treatment options and future research to increase hepatitis C virus treatment response rate
Critical appraisal of the role of sorafenib in the management of hepatocellular carcinoma
Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection
Pathogenesis and management of alcoholic liver cirrhosis: a review
Epidemiology and treatment of autoimmune hepatitis
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio